Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    These changes reflect updates to the study record's update history, with May 2026 timestamps added and April 2026 timestamps removed. They indicate edits to the page's metadata rather than changes to the study's design, eligibility, or outcomes.
    Difference
    0.1%
    Check dated 2026-05-11T11:45:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Two trial sites were updated: Liuzhou, China (545026) and Taoyuan, Taiwan (33382) were added, while Liuchow, China (545026) and Taoyuan District, Taiwan (33382) were removed.
    Difference
    0.0%
    Check dated 2026-05-04T07:41:13.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s footer “Revision” indicator is updated from v3.5.2 to v3.5.3, reflecting a minor update to the site software/versioning without changing the displayed trial content.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Additions: 2026-04-13, 2026-04-09, 2026-04 and Revision: v3.5.2. Deletions: 2026-03-16, 2026-03-12, 2026-03 and Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T02:48:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 has been added to the locations and Padua, Italy, 35128 has been removed.
    Difference
    0.0%
    Check dated 2026-04-05T17:13:18.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision notes show the page updated to version 3.5.0 (2026-03-16) with related changes, and the earlier version 3.4.3 (2026-02-12) removed.
    Difference
    0.1%
    Check dated 2026-03-22T08:40:46.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.